Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Renew Biotechnologies Appoints Steven Abbott As Chief Operating Officer (COO)

PRIVATEJul 25, 2024•almost 2 years ago

Position

Chief Operating Officer

Company

Renew Biotechnologies

Steven Abbott
ProvoBiotechnologyHealth Care

Description

Renew Biotechnologies has appointed Steven Abbott as Chief Operating Officer (COO), bringing extensive experience in genomics and biotechnology operations to lead Wasatch BioLabs, a core Renew Biotechnologies subsidiary, from its current research and development phase into full-scale commercial operations.

Company Information

Company

Renew Biotechnologies

Location

Provo, Utah, United States

About

Renew Biotechnologies is at the forefront of revolutionizing clinical diagnostics by developing and launching a series of specialized biotechnology companies. By collaborating with healthcare and industry leaders, Renew Biotechnologies aims to equip researchers and providers with genomic and epigenomic tools that enhance decision-making and improve patient outcomes. Each subsidiary is dedicated to transforming healthcare, one breakthrough at a time.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Renew Biotechnologies's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.